These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23340201)

  • 21. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response.
    Arthur D; Levin ED
    Psychopharmacology (Berl); 2002 Mar; 160(2):140-5. PubMed ID: 11875631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice.
    Shim SB; Lee SH; Chae KR; Kim CK; Hwang DY; Kim BG; Jee SW; Lee SH; Sin JS; Bae CJ; Lee BC; Lee HH; Kim YK
    Neurochem Res; 2008 Sep; 33(9):1783-8. PubMed ID: 18307030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
    Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
    Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery.
    Papke RL; Dwoskin LP; Crooks PA
    J Neurochem; 2007 Apr; 101(1):160-7. PubMed ID: 17241116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.
    Ke L; Eisenhour CM; Bencherif M; Lukas RJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):825-40. PubMed ID: 9694939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo.
    Miwa JM; Stevens TR; King SL; Caldarone BJ; Ibanez-Tallon I; Xiao C; Fitzsimonds RM; Pavlides C; Lester HA; Picciotto MR; Heintz N
    Neuron; 2006 Sep; 51(5):587-600. PubMed ID: 16950157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptors.
    Zhang J; Xiao YD; Jordan KG; Hammond PS; Van Dyke KM; Mazurov AA; Speake JD; Lippiello PM; James JW; Letchworth SR; Bencherif M; Hauser TA
    Eur J Pharm Sci; 2012 Dec; 47(5):813-23. PubMed ID: 23036283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
    Newhouse PA; Potter A; Levin ED
    Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinic receptor subtypes and cognitive function.
    Levin ED
    J Neurobiol; 2002 Dec; 53(4):633-40. PubMed ID: 12436426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
    Verma S; Kumar A; Tripathi T; Kumar A
    J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZY-1, a novel nicotinic analog, promotes proliferation and migration of adult hippocampal neural stem/progenitor cells.
    He N; Wang Z; Wang Y; Shen H; Yin M
    Cell Mol Neurobiol; 2013 Nov; 33(8):1149-57. PubMed ID: 24057433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.
    Meyer PM; Tiepolt S; Barthel H; Hesse S; Sabri O
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):376-86. PubMed ID: 25387119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer's Disease: The Role of Protein-Protein Interactions in Current and Future Treatment.
    Thomsen MS; Andreasen JT; Arvaniti M; Kohlmeier KA
    Curr Pharm Des; 2016; 22(14):2015-34. PubMed ID: 26818866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease.
    Jensen MM; Arvaniti M; Mikkelsen JD; Michalski D; Pinborg LH; Härtig W; Thomsen MS
    Neurobiol Aging; 2015 Apr; 36(4):1629-1638. PubMed ID: 25680266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of an alpha7 nicotinic receptor agonist and stress on spatial memory in an animal model of Alzheimer's disease.
    Vicens P; Ribes D; Heredia L; Torrente M; Domingo JL
    Biomed Res Int; 2013; 2013():952719. PubMed ID: 24058919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
    Levin ED; McClernon FJ; Rezvani AH
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):523-39. PubMed ID: 16220335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of nicotinic drug therapy for cognitive disorders.
    Levin ED; Rezvani AH
    Eur J Pharmacol; 2000 Mar; 393(1-3):141-6. PubMed ID: 10771007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.